16-01-2022, 04:52 PM
Previously, investigations showed that Covaxin (BBV152) might neutralize SARS-CoV-2 strains of Concern Alpha, Beta, Delta, Zeta, and Kappa.
Bharat Biotech, the developer of Covaxin, said in a statement that booster doses of the vaccine provide strong neutralizing antibody responses against both the Omicron (B.1.529) and Delta (B.1.617.2) coronavirus variants.
According to the findings of the tests, 100% of the serum samples showed neutralization of the Delta variant and more than 90% of the serum samples showed neutralization of the Omicron variant, as said by Bharat Biotech.
https://www.opindia.com/2022/01/study-co...a-variant/
Bharat Biotech, the developer of Covaxin, said in a statement that booster doses of the vaccine provide strong neutralizing antibody responses against both the Omicron (B.1.529) and Delta (B.1.617.2) coronavirus variants.
According to the findings of the tests, 100% of the serum samples showed neutralization of the Delta variant and more than 90% of the serum samples showed neutralization of the Omicron variant, as said by Bharat Biotech.
https://www.opindia.com/2022/01/study-co...a-variant/